| SCHRODER ISF JAPANESE OPPORTUNITIES C ACC JPY | RVI JAPÓN VALOR | 28,86% | 64,44% | 73,07% | 133,74% |
| AXA WORLD FUNDS-ACT EUROZONE EQUITY F CAP EUR | RV EURO | 19,26% | 51,36% | 36,19% | 133,73% |
| GOLDMAN SACHS INDIA EQUITY PORTFOLIO I GBP DIS | RVI INDIA | -2,84% | 16,09% | 27,66% | 133,73% |
| INVESCO JPX-NIKKEI 400 UCITS ETF ACC | RVI JAPÓN | 26,58% | 62,39% | 63,72% | 133,72% |
| LO FUNDS - TARGETNETZERO EUROPE EQUITY (EUR) N CAP | RVI EUROPA | 18,81% | · | 54,73% | 133,71% |
| JPM EUROPE STRATEGIC DIVIDEND A (ACC) EUR | RVI EUROPA VALOR | 26,02% | 80,72% | 84,48% | 133,70% |
| TEMPLETON ASIAN GROWTH I (ACC) USD | RVI ASIA EX-JAPÓN CRECIMIENTO | 52,82% | 87,40% | 51,09% | 133,70% |
| ALLIANZ GLOBAL SMALL CAP EQUITY IT (H-EUR) EUR | RVI GLOBAL SMALL/MID CAP | 27,93% | 59,15% | 35,57% | 133,66% |
| AB SICAV I-EUROPEAN EQUITY PORTFOLIO S1X USD | RVI EUROPA | 19,96% | 49,07% | 51,45% | 133,65% |
| ISHARES MSCI JAPAN UCITS ETF USD (ACC) | RVI JAPÓN | 27,44% | 64,63% | 62,77% | 133,65% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 69,06% | 111,68% | 62,68% | 133,62% |
| GOLDMAN SACHS EUROPE SUSTAINABLE EQUITY I CAP EUR | RVI EUROPA | 8,25% | 36,06% | 22,39% | 133,61% |
| BNP PARIBAS GREEN TIGERS I CAP | RVI ECOLOGÍA | 45,57% | 64,71% | 36,16% | 133,60% |
| GOLDMAN SACHS INDIA EQUITY PORTFOLIO R USD DIS | RVI INDIA | -2,77% | 16,08% | 27,02% | 133,59% |
| JPM EMERGING MARKETS EQUITY C (DIST) USD | RVI EMERGENTES | 46,41% | 71,14% | 28,94% | 133,56% |
| FIDELITY FUNDS-SUSTAINABLE EUROZONE EQUITY Y-ACC-EUR | RV EURO | 12,77% | 38,53% | 32,00% | 133,54% |
| AB SICAV I-INTERNATIONAL HEALTH CARE PORTFOLIO A EUR | RVI SALUD | 20,30% | 12,36% | 19,51% | 133,44% |
| BGF EUROPEAN VALUE A2 USD | RVI EUROPA VALOR | 19,17% | 62,83% | 73,53% | 133,44% |
| BARINGS GLOBAL EMERGING MARKETS FUND A USD CAP | RVI EMERGENTES | 45,56% | 74,72% | 57,27% | 133,30% |
| FIDELITY FUNDS-GLOBAL THEMATIC OPPORTUNITIES Y-ACC-USD | RVI GLOBAL | 21,73% | 55,48% | 39,74% | 133,27% |
